Patterson Cos Agrees to Be Acquired by Patient Square in $4.1B Deal

Dow Jones
2024-12-11
 

By Denny Jacob

 

Patterson Cos. agreed to be acquired by health-care investment firm Patient Square Capital in a deal valued around $4.1 billion.

The dental and animal health-care company said its shareholders will receive $31.35 a share in cash, a roughly 49% premium to its 30-calendar-day, volume-weighted average price ending Dec. 4, the last trading day before it announced an evaluation of strategic alternatives. The value of the deal includes the refinancing of Patterson's receivables facilities.

Patterson shares closed Tuesday at $23.11. The stock is down about 19% from the start of the year.

Patterson's board, excluding Chief Executive Don Zurbay--given his position as a management director--unanimously approved the transaction. It is expected to close in the fourth quarter of Patterson's fiscal 2025, at which time the company will go private.

The merger agreement includes a 40-day "go-shop" period that permits Patterson's board and its advisers to actively solicit alternative acquisition proposals.

Patient Square has about $11 billion in assets as of Sept. 30. Its portfolio includes companies such as Access TeleCare and Apollo Therapeutics, according to its website.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

December 11, 2024 07:24 ET (12:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10